パリ +

Giorgi Gugenishvili assists French and international clients in contentious and noncontentious matters related to intellectual property (trademarks, copyright, domain names, patents), data protection, and information technology.

Prior to joining Jones Day in 2023, Giorgi completed internships at several international law firms, a leading French communications company, and a prominent French start-up in the gaming industry. While at university, he also worked as a legal research assistant on a European Research Council-funded project.


  • Amolyt Pharma enters into definitive agreement to be acquired by AstraZenecaJones Day is advising Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.